đź“‹ FDA Reference
dermagran hydrophilic wound dressing
Derma Sciences
Summary: The Dermagran Hydrophilic Wound Dressing is a medical device used for managing wound exudate and promoting a moist wound environment. It is typically used by wound care specialists and healthcare providers in various clinical settings.
FDA Clearance Information
Pathway
510K
Number
K954738 ↗
Decision Date
November 2, 1995
Product Code
MGP
Device Class
—
Evidence
419 studies
The Dermagran Hydrophilic Wound Dressing was cleared through the FDA 510(k) pathway on November 2, 1995. Manufactured by Derma Sciences, it is classified under product code MGP with no specific class designation.
What It Is
The Dermagran Hydrophilic Wound Dressing is a type of wound dressing designed to manage exudate and maintain a moist environment conducive to healing. It works by absorbing excess fluid from the wound while preventing dehydration of the wound bed. This helps in promoting natural healing processes and protecting the wound from external contaminants.
Clinical Applications
This dressing is commonly used in the management of various types of wounds, including pressure ulcers, surgical incisions, and traumatic wounds. It is particularly useful in settings such as hospitals, outpatient clinics, and home care, where maintaining a moist wound environment is crucial. Wound care specialists, nurses, and other healthcare providers frequently utilize this dressing in their practice.
Indications for Use
The FDA indications for the Dermagran Hydrophilic Wound Dressing suggest its use in managing wounds that require moisture balance. It is suitable for patients with wounds that have moderate to heavy exudate, helping to facilitate the healing process.
Practical Considerations
The dressing is available in various sizes to accommodate different wound types and locations. It is important to ensure proper sizing and secure application to optimize its effectiveness. Compatibility with other wound care products should be considered when developing a comprehensive wound management plan.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Dermagran Hydrophilic Wound Dressing used for?
It is used for managing wound exudate and maintaining a moist environment to promote healing.
What specialties typically use this device?
Wound care specialists, nurses, and healthcare providers in hospitals, clinics, and home care settings.
What are the FDA-cleared indications?
The dressing is indicated for wounds requiring moisture balance, particularly those with moderate to heavy exudate.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.